A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer
Table 1
Number of deleterious mutations (fD), polymorphism/neutral variants (fP) and cancer association (fD/fP) in each vaccine target.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Number of deleterious mutations (fD), polymorphism/neutral variants (fP) and cancer association (fD/fP) in each vaccine target.